Table 1 Baseline characteristics analysis
Characteristics | Live N = 25 | Death N = 34 | P-value | Statistic analysis method |
|---|---|---|---|---|
Gender (male/female) | 18/7 | 18/16 | 0.141 | U-test |
Age | 52.08 ± 10.99 | 56.38 ± 8.30 | 0.092 | T-test |
Location of onset (bulb/limb) | 8/17 | 11/23 | 0.977 | U-test |
Time from onset to diagnosis(months) | 13.04 ± 10.67 | 15.50 ± 26.31 | 0.661 | T-test |
Riluzole treatment(yes/no) | 18/7 | 15/19 | 0.035 | U-test |
Average ALSFRS-R score | 44.32 ± 3.17 | 43.59 ± 2.58 | 0.333 | T-test |
Average survival time(months) | 46.08 ± 24.20 | 49.03 ± 29.86 | 0.687 | T-test |
⊿FS | 0.76 ± 1.60 | 0.65 ± 0.78 | 0.739 | T-test |
ventilator-assisted(yes/no) | 17/8 | 21/13 | 0.212 | U-test |